Isopropylamine

Isopropylamine

SCHEMBL3581231

CC(C)N.O=C(O)C1=C(c2ccccc2)c2ccc(O)cc2C1=O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 6/20 0.63
FGFR2 P21802 6/20 0.63
FGFR4 P22455 6/20 0.63
FGFR3 P22607 6/20 0.63
ESR2 Q92731 9/20 0.57
ESR1 P03372 8/20 0.57
SRC P12931 4/20 0.52
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
MAOA P21397 1/20 0.45
UGT1A1 P22309 1/20 0.45
MAOB P27338 1/20 0.45
PPARG P37231 2/20 0.44
P2RX7 Q99572 1/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
XBP1 P17861 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3575957 0.92 FGFR1 (0.70) FGFR1FGFR2FGFR4FGFR3ESR2
SCHEMBL4656306 0.84 FGFR1 (0.68) FGFR1FGFR2FGFR4FGFR3ESR2
SCHEMBL3578768 0.80 FGFR1 (0.74) FGFR1FGFR2FGFR4FGFR3ESR2
SCHEMBL147279 0.79 FGFR1 (1.00) FGFR1FGFR2FGFR4FGFR3SRC
SCHEMBL3570952 0.76 PPARG (0.74) FGFR1FGFR2FGFR4FGFR3ESR2
SCHEMBL4656549 0.75 FGFR1 (0.48) FGFR1FGFR2FGFR4FGFR3ESR2
SCHEMBL4658483 0.75 PPARG (0.73) FGFR1FGFR2FGFR4FGFR3SRC
SCHEMBL3922937 0.73 ESR2 (1.00) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL4655931 0.73 PPARG (0.71) FGFR1FGFR2FGFR4FGFR3ESR2
SCHEMBL13770821 0.72 FGFR1 (0.85) FGFR1FGFR2FGFR4FGFR3ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741323-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-22 US disclosed
US-20070185109-A1 Idene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2007-08-09 US disclosed
EP-1740531-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-01-10 EP disclosed
WO-2005100303-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185109-A1 Idene derivatives and process for the preparation thereof INSR, PPARD, GPR119 FGFR1 134/4885FGFR2 236/4885FGFR4 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.